Agustin Melian's Insider Trades & SAST Disclosures
Agustin Melian's most recent trade in Kalaris Therapeutics Inc. was a trade of 10,678 Common Stock done at an average price of $23.3 . Disclosure was reported to the exchange on Oct. 4, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Agustin Melian.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.29 per share. | 04 Oct 2021 | 10,678 | 461,540 | - | 23.3 | 248,690 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.23 per share. | 04 Oct 2021 | 4,711 | 456,829 | - | 24.2 | 114,129 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.41 per share. | 04 Oct 2021 | 2,967 | 453,862 | - | 25.4 | 75,377 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 04 Oct 2021 | 333 | 453,529 | - | 26.0 | 8,666 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.12 per share. | 28 Sep 2021 | 3,750 | 472,218 | - | 24.1 | 90,432 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.99 per share. | 05 Apr 2021 | 18,586 | 479,718 | - | 20.0 | 371,534 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 05 Apr 2021 | 18,212 | 498,304 | - | 23.9 | 435,085 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.01 per share. | 05 Apr 2021 | 2,950 | 475,968 | - | 24.0 | 70,842 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.03 per share. | 05 Apr 2021 | 800 | 478,918 | - | 24.0 | 19,224 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.97 per share. | 22 Mar 2021 | 3,750 | 516,516 | - | 26.0 | 97,394 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.19 per share. | 02 Feb 2021 | 54,849 | 520,266 | - | 41.2 | 2,259,230 | Common Stock |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 81,250 | 81,250 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 43,750 | 575,115 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Agustin Melian | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 220,700 | 220,700 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges